Company attributes
Industry
B2X
Founder
Date Incorporated
October 28, 2002
Number of Employees (Ranges)
51 – 200
Full Address
100 BEAVER STREET, WALTHAM, MA, 02453
CIK Number
DUNS Number
1277209230
IRS Number
43,714,1890
Total Funding Amount (USD)
55,500,000
Latest Funding Round Date
August 2007
Latest Funding Type
CAGE Code
4J5T30
Patents Assigned (Count)
1
Other attributes
Company Operating Status
Closed
Previous Name
COMPOUND THERAPEUTICS INC0
SIC Code
2,8340
Adnexus Therapeutics, founded in 2003,and acquired by Bristol-Myers Squibb was a biopharmaceutical company focused on the development and commercialization of Adnectins as a class of therapeutics based on human fibronectin.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
